Record Q4 sales and first positive EBITDA mark a milestone, driven by core product growth and cost reductions. Strategic partnership with Ferring Pharmaceuticals and new product launches position the company for future expansion.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
